Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists hunt for immune clues in rare lung disease

NCT ID NCT01208792

First seen Oct 31, 2025 · Last updated Apr 30, 2026 · Updated 29 times

Summary

This study looked at whether certain immune system markers (autoantibodies) can help predict the course of pulmonary arterial hypertension (PAH), a serious lung condition. Researchers examined blood samples from 629 adults with different types of PAH, including those linked to HIV, congenital heart defects, and connective tissue diseases. The goal was to better understand the role of the immune system in PAH, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Internal Medicine Department, Claude Huriez Hospital

    Lille, 59000, France

  • Internal Medicine Department, Cochin Hospital

    Paris, 75014, France

  • Pneumology Department, Antoine Béclère Hospital

    Clamart, 92000, France

Conditions

Explore the condition pages connected to this study.